NOS3 and coronary artery disorder: This evidence suggests that the presence of either one of the eNOS polymorphisms leads to a compromise of the endothelium-dependent vasodilatory capacity of large conduit vessels; thus, representing an additional factor to the classical risk factors in patients with CAD [36].